所有产品
  • 抗体
  • 试剂盒
  • 多肽
  • 蛋白
  • 生化试剂
  • 组织芯片
EN
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
抗体药类似物
当前位置：首页 > 产品中心 > 抗体 > 抗体药类似物
产品中心
Product Center
Research Grade Tibulizumab
All
SDS-PAGE
Bioactivity
  • Catalog： TD-HS856106
  • Clonality： Monoclonal
  • Application： ELISA, Bioactivity: FACS, Functional assay, Research in vivo
  • Synonyms： Bispecific, LY 3090106, LY-3090106, LY3090106, 1849636-24-3
  • 规格：
    询价
  • 价格：
    ¥100ug
定制服务咨询
详细相关信息
FAQ
实验方案
参考文献
  • Catalog No.
    TD-HS856106
  • Description
    Research Grade Tibulizumab(TD-HS856106) is ahumanized monoclonalantibody detectingCTLA-8inELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable forHuman.HighlightsMulti-Application— Validated across multiple applications.
  • Species reactivity
    Human
  • Applications
    ELISA, Bioactivity: FACS, Functional assay, Research in vivo
  • Host species
    Humanized
  • Isotype
    IgG4-kappa-[scFv]2
  • Species
    Human
  • Clonality
    Monoclonal
  • Target
    CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
  • Endotoxin level
    Please contact with the lab for this information.
  • Purity
    >95% as determined by SDS-PAGE.
  • Purification
    Protein A/G purified from cell culture supernatant.
  • Accession
    Q16552 & Q9Y275
  • Form
    Liquid
  • Storage buffer
    0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
  • Stability and Storage
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
  • Alternate Names
    Bispecific, LY 3090106, LY-3090106, LY3090106, 1849636-24-3
  • Background
    Tibulizumab (LY-3090106) is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
  • Caption
    SDS-PAGE for Research Grade Tibulizumab.　　|　Detects Human IL17A in direct ELISAs.
  • Note
    For research use only. Not suitable for clinical or therapeutic use.